Measuring Tumor Epichaperome Expression Using [124I] PU-H71 Positron Emission Tomography as a Biomarker of Response for PU-H71 Plus Nab-Paclitaxel in HER2-Negative Metastatic Breast Cancer For ...
New FDA guidance on the use of Bayesian statistics signals a broader shift in accommodating more flexible clinical trial ...
The adoption of high-fidelity models in multidisciplinary design optimization (MDO) permits to enhance the identification of superior design configurations, but would prohibitively rise the demand for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results